LONDON--(BUSINESS WIRE)--The dramatic increase in the rate of cancer, coupled with the need for early detection, is driving the worldwide demand for biopsy devices. In Europe, the market for biopsy devices is facing challenges such as fierce competition and lack of reimbursements. Despite the dominance of tier I participants, there is still a significant level of competition among smaller participants for market share.
